Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy

Autor: U Melnyk, N Goryainova, T Perekhrestenko, I Diagil

Publikováno v: Experimental oncology. 42(2)

Aim To assess the expression of Ki-67 protein and CD34 antigen on peripheral blood (PB) and bone marrow (BM) cells in chronic myelogenous leukemia (CML) patients with different response to tyrosine kinase inhibitors (TKI) imatinib (IM) and nilotinib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29243d72c1a7d5452fe4214ad855e440
https://pubmed.ncbi.nlm.nih.gov/32602293

PF402 PECULIARITIES OF THE EXPRESSION OF KI-67 AND CD34 HEMOPOIETIC PRECURSOR CELLS IN PB AND BM OF CML PATIENTS WITH THE DIFFERENT RESPONSES TO IMATINIB AND NILOTINIB THERAPY

Autor: I. Sviezhentseva, T. Perekhrestenko, U. Melnyk, I. Dyagil

Publikováno v: HemaSphere. 3:153

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4129b5f3bba282b804a2eda0da1f15e8
https://doi.org/10.1097/01.hs9.0000559820.77165.80

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Retraction Note: Primary hemostasis dysfunctions and bleeding risk in newly diagnosed acute myeloid leukemia.

Autor: Stupakova Z; Department of Radiologic Hematology, National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine. zinaidastupakova1@gmail.com., Diagil I; Department of Radiologic Hematology, National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine., Melnyk U; Kyiv City Clinical Hospital, No. 9, Kyiv, Ukraine., Karnabeda O; Bogomolets National Medical University, Kyiv, Ukraine., Sergeieva A; Department of Radiologic Hematology, National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine.

Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Dec 04; Vol. 150 (12), pp. 517. Date of Electronic Publication: 2024 Dec 04.